Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis

International Journal of Molecular Medicine

Volumn 27, Issue 1, 2011, Pages 87-94

  Zhang, Ying ^a   Cao, Hong ^a,b   Hu, Yue Yue ^a   Wang, Hua ^a   Zhang, Chang Jun ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Endometriosis; Microvessel density; Vascular endothelial growth factor

Indexed keywords

CURCUMIN; DRUG VEHICLE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; ENDOMETRIOSIS; ENDOMETRIUM; ESTRUS CYCLE; EVIDENCE BASED PRACTICE; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CURCUMIN; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 78651088891     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2010.552     Document Type: Article

References (33)

1. Garcia Manero M, Olartecoechea B, Royo Manero P, Auba M and Lopez G: [Endometriosis]. Rev Med Univ Navarra 53: 4-7, 2009.
2. Cramer DW and Missmer SA: The epidemiology of endometriosis. Ann NY Acad Sci 955: 11-22, 2002.
3. The Practice Committee of the American Society for Reproductive Medicine: Endometriosis and infertility. Fertil Steril 81: 1441-1446, 2004.
4. Abulafia O and Sherer DM: Angiogenesis of the endometrium. Obstet Gynecol 94: 148-153, 1999.
5. Laschke MW and Menger MD: In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 13: 331-342, 2007.
6. Taylor RN, Yu J, Torres PB, Schickedanz AC, Park JK, Mueller MD and Sidell N: Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 16: 140-146, 2009.
7. McLaren J: Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 6: 45-55, 2000.
8. Goteri G, Lucarini G, Filosa A, et al: Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata. Fertil Steril 81: 1528-1533, 2004.
9. Flower A, Lewith GT and Little P: Seeking an oracle: using the Delphi process to develop practice guidelines for the treatment of endometriosis with Chinese herbal medicine. J Altern Complement Med 13: 969-976, 2007.
10. Wieser F, Cohen M, Gaeddert A, Yu J, Burks-Wicks C, Berga SL and Taylor RN: Evolution of medical treatment for endometriosis: back to the roots? Hum Reprod Update 13: 487-499, 2007.
11. Lin YG, Kunnumakkara AB, Nair A, et al: Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res 13: 3423-3430, 2007.
12. Bhattacharyya S, Mandal D, Sen GS, et al: Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. Cancer Res 67: 362-370, 2007.
13. Perry MC, Demeule M, Regina A, Moumdjian R and Beliveau R: Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts. Mol Nutr Food Res 58: 1192-1201, 2010.
14. Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H and Patumraj S: Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc 34: 109-115, 2006.
15. Haber E, Danenberg HD, Koroukhov N, Ron-El R, Golomb G and Schachter M: Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model. Hum Reprod 24: 398-407, 2009.
16. Dizerega GS, Barber DL and Hodgen GD: Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression. Fertil Steril 33: 649-653, 1980.
17. Zeitoun K, Takayama K, Sasano H, et al: Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 83: 4474-4480, 1998.
18. Hong M and Zhu Q: Macrophages are activated by 17beta-estradiol: possible permission role in endometriosis. Exp Toxicol Pathol 55: 385-391, 2004.
19. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
20. Sampson JA: Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 3: 93-110 143, 1927.
21. Smith SK: Angiogenesis. Semin Reprod Endocrinol 15: 221-227, 1997.
22. Schindl M, Birner P, Obermair A, Kiesel L and Wenzl R: Increased microvessel density in adenomyosis uteri. Fertil Steril 75: 131-135, 2001.
23. Khan KN, Masuzaki H and Fujishita A: Imunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium. Fertil Steril 79: 173-181, 2003.
24. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH and Zhu L: Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 78: 148-153, 2002.
25. Bourlev V, Volkov N, Pavlovitch S, Lets N, Larsson A and Olovsson M: The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction 132: 501-509, 2006.
26. Ferrara N and Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858, 1989.
27. Mahnke JL, Dawood MY and Huang JC: Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril 73: 166-170, 2000.
28. Na YJ, Yang SH, Baek DW, et al: Effects of peritoneal fluid from endometriosis patients on the release of vascular endothelial growth factor by neutrophils and monocytes. Hum Reprod 21: 1846-1855, 2006.
29. McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Muller KH, Sharkey AM and Smith SK: Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 98: 482-489, 1996. (Pubitemid 26255749)
30. Machado DE, Abrao MS, Berardo PT, Takiya CM and Nasciutti LE: Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endo-metriosis affecting the rectum. Fertil Steril 90: 148-155, 2008.
31. Burns JW, Skinner K, Colt J, Sheidlin A, Bronson R, Yaacobi Y and Goldberg EP: Prevention of tissue injury and postsurgical adhesions by precoating tissues with hyaluronic acid solutions. J Surg Res 59: 644-652, 1995.
32. Sharma RA, Euden SA, Platton SL, et al: Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10: 6847-6854, 2004.
33. Cheng AL, Hsu CH, Lin JK, et al: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900, 2001.